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http:WHAT THIS PAPER ADDS
Endograft selection may play an important role in the outcome of EVAR. This study assesses and grades the
inﬂuence of several patient related characteristics on the occurrence of proximal neck related complications
using a late generation device that was designed speciﬁcally to cope with more challenging proximal neck
anatomy. The results suggest that neck length remains the most relevant risk factor. Moreover, other conven-
tional risk factors such as angulation or neck taper seem to have little inﬂuence in the short and mid-term.
Comparing these results with those of other large single device registries may help clinicians select the cor-
rect endoprosthesis for individual patients, optimizing the results of EVAR.Objective: To assess the incidence and risk factors for proximal aneurysm neck related complications with a late
generation device for endovascular abdominal aneurysm repair (EVAR).
Methods: Data were retrieved from a prospective registry (Endurant Stent Graft Natural Selection Global
Postmarket Registry) involving 79 institutions worldwide. The risk factors tested were age, gender, surgical risk
proﬁle, proximal neck length (<10 mm), diameter (>30 mm), supra- and infrarenal angulation (>60 and 75),
mural thrombus/calciﬁcation (>50%) and taper (>10%), and AAA diameter (>65 mm). Two neck related
composite endpoints were used, for intra-operative (type-1a endoleak, conversion, deployment/retrieval
complication or unintentional renal coverage) and post-operative (type-1a endoleak or migration) adverse
events. Independent risk factors were identiﬁed using multivariable backwards modeling.
Results: The study included 1263 patients (mean age 73, 10.3% female) from March 2009 to May 2011. Twenty
three (1.8%) intra-operative adverse events occurred. Neck length <10 mm (OR 4.9, 95% CI 1.1e22.6) and neck
thrombus/calciﬁcation >50% (OR 4.8, 95% CI 1.7e13.5) were risk factors for intra-operative events. The planned
1 year follow up visit was reached for the entire cohort, and the 2 year visit for 431 patients. During this time, 99
(7.8%) events occurred. Female gender (HR 1.9, 95% CI 1.1e3.2), aneurysm diameter >65 mm (HR 2.8, 95% CI
1.9e4.2), and neck length <10 mm (HR 2.8, 95% CI 1.1e6.9) were signiﬁcant post-operative risk factors. Neck
angulation, neck taper, large diameter neck, and presence of thrombus/calciﬁcation were not predictors of
adverse outcome in this study.
Conclusion: These results support the adequacy of this device in the face of adverse neck anatomy, and conﬁrm
neck length as the most relevant anatomical limitation for EVAR. Additionally, the study conﬁrms the decline in
early to mid-term intervention rates with a newer generation device in a large patient sample. Lastly, it suggests
that neck related risk factors affect outcome and impact on prognosis in varying degrees.
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Endovascular aneurysm repair (EVAR) is an accepted treat-
ment modality for infrarenal abdominal aortic aneurysms
(AAA). Technical and technological innovations have been
progressively introduced over the last two decades, gener-
ally leading to improved early and late outcomes. Careful
evaluation of newly introduced devices for EVAR is essential
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gradually expanding indications.
The most limiting factor for EVAR is adverse proximal
neck anatomy.1 Extensive research has shown that charac-
teristics of the proximal neck, such as length, diameter,
angulation, taper, and irregularity affect outcome signiﬁ-
cantly.1e6 Manufacturers have focused much attention on
proximal neck limitations in their Instructions For Use (IFU),
which are the most common reason for ruling out EVAR.
The Endurant Stent Graft System (Medtronic, Santa Rosa,
CA, USA) has been speciﬁcally designed to cope with un-
favorable anatomic characteristics, therefore potentially
expanding the treatment range for EVAR. Speciﬁcally, the
proximal geometry of the main body stents allow for extra
ﬂexibility and conformability, while maintaining adequate
radial force. Also, the suprarenal active ﬁxation and precise
tip capture deployment mechanism are designed for more
precise and controlled deployment and durable ﬁxation. The
manufacturers’ expectations on the performance of this
device are reﬂected in the IFU, which are among the most
liberal. Even so, physicians often exceed these recommen-
dations, with the expectation of reduced complications
during follow up.
Very favorable outcomes have been reported in small
series of patients with adverse neck features. However,
these studies are generally retrospective and based on
single institution experiences, and therefore subject to
publication bias. The objective of this study is to assess the
importance of different adverse anatomical characteristics
of the proximal attachment site when using a late genera-
tion device. To do so, a large prospective, multicenter
cohort of patients from the Endurant Stent Graft Natural
Selection Global Postmarket Registry (ENGAGE) was
studied.METHODS
Eligibility
Patients with AAAs considered suitable for elective endo-
vascular repair were eligible for inclusion in this registry.
Although adherence to IFU was advised, enrollment of pa-
tients outside IFU was permitted. Enrolment was conducted
on an intention to treat basis, and a minimum of ﬁve
consecutive patients per center was advised. Unfortunately,
no information is available on the number of patients
offered EVAR with other devices, open repair, or no treat-
ment for each participating center, and therefore the extent
of selection bias is impossible to determine. However, all
patients included in the registry were also included in this
study. All patients were asked for signed informed consent.
The study was conducted according to the Helsinki decla-
ration on research ethics and registered under the
ClinicalTrials.gov Identiﬁer> NCT00890051.Data collection and deﬁnitions
Individual patient data were entered prospectively by
participating hospitals and stored electronically locally. Thepre-operative data collected included demographics, medi-
cal comorbidities (smoking, hypertension, hyperlipidemia,
diabetes, cardiac disease, pulmonary disease, renal insufﬁ-
ciency, cerebrovascular disease, and peripheral arterial
disease), and anatomical characteristics (proximal neck
diameter, length, angle, presence of mural neck thrombus/
calciﬁcation, neck taper, and AAA maximum diameter).
Intra-operative details included technical success, presence
of type Ia or undetermined endoleak, additional devices
used, and procedures performed during the implant pro-
cedure. Follow up visits were scheduled at 30 days, 1, and 2
years, with mandatory imaging studies. At follow up visits,
any protocol deﬁned adverse event was registered and
imaging studies were assessed for the presence of compli-
cations and AAA maximum diameter changes. Any sec-
ondary procedures were also registered. External auditors
closely monitored all clinical data in this registry.
For this study, candidate adverse neck characteristics
were selected on the basis of previous literature and ac-
counting for the recommended anatomical limits for this
particular device. Speciﬁcally, the chosen cutoffs for adverse
neck were length <10 mm, presence of thrombus/calciﬁ-
cation >50%, and neck angulation greater than 60 (supra-
renal) or 75 (infra-renal). In addition, the presence of neck
taper>15% and large diameter aortic necks (requiring 32 or
36 mm proximal diameter endoprosthesis) were considered
as potential risk candidates based on previous literature.
Surgical risk was calculated according to the modiﬁed Lee
score and ASA classiﬁcation. Migration was deﬁned as
downward displacement of the endograft by at least
10 mm. Sac growth was deﬁned as an increase in maximum
aneurysm diameter of at least 5 mm, as recommended in
the SVS reporting standards.7
Study endpoints
For this study, two composite endpoints were chosen: for
intra-operative neck related adverse events, the endpoint
was composed of intra-operative (or undetermined) type Ia
endoleak, unintentional renal artery coverage, presence of
deployment or retrieval complication or need for conver-
sion to open repair. For post-operative neck related adverse
events, the endpoint was composed of any postoperative
type Ia (or undetermined) endoleak, proximal device
migration, need for proximal neck secondary intervention
or post-implantation rupture. The individual components of
each endpoint were also studied to assess their speciﬁc
contribution to the endpoint.
Statistical methods
Categorical variables were presented as count and per-
centage and compared with Pearson’s chi-square tests.
Continuous variables were presented as mean and standard
deviation (SD) and compared using Student t tests if nor-
mally distributed, or presented as median and interquartile
range (IQR) and compared with ManneWhitney U tests if
the distribution was skewed. Each variable of interest (age,
gender, baseline AAA diameter, ASA classiﬁcation, proximal
Table 2. Intra-operative neck related adverse events.
Intra-operative neck related adverse events N ¼ 1263
N (%)
Endoleak type 1a 12 (1.0)
Corrected by remodeling the stent graft 3/12 (25)
Corrected with extension cuffs (prox or dist) 3/12 (25)
Corrected (others) 1/12 (8)
Conversion to open repair 4 (0.3)
Unintentional renal artery coverage (partial/total) 5 (0.4)
Deployment/retrieval complication 7 (0.6)
Total (patients) 23 (1.8)
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thrombus or calciﬁcation, proximal neck taper, supra- and
infra-renal angle) was tested separately as a risk factor for
intra-operative and post-operative neck related adverse
events, and independent signiﬁcance was tested for vari-
ables with p < .1 using multivariate logistic regression and
proportional hazard regression, respectively. Based on the
hazard ratios obtained for signiﬁcant risk factors for post-
operative neck related adverse events, a risk model was
generated and tested using the area under the curve of the
resulting receiver operating characteristic curve (ROC). A
cutoff was determined based on the optimal sensitivity and
speciﬁcity of the test (maximum sum value method), and
patients scoring greater than the cutoff were considered
high risk. KaplaneMeier survival estimates were calculated
for freedom from neck related adverse events and
compared using the Log Rank (Mantel-Cox) test of equality.
Differences were considered signiﬁcant if p < .05. Statistical
analysis was performed by an independent statistical ofﬁce
(Secic Statistical Consulting, Inc), using IBM SPSS Statistics
20 (IBM Inc., Chicago, IL, USA).RESULTS
From March 2009 to May 2011, 1263 patients were
included in the ENGAGE registry and were included in the
present study. All patients had an expected minimum follow
up of 1 year and a maximum of 3 years. At the time of this
study, all surviving patients had reached the 1 year mark
and 431 (38%) had reached the 2 year mark. Baseline
characteristics are detailed in Table 1.Table 3. Uni- and multivariate model for intra-operative adverseIntra-operative neck related adverse events
Twenty three patients (1.9%) suffered from intra-operative
neck related adverse events. The majority were type Ia
endoleaks (N ¼ 12, 1.0%), of which seven were corrected
intra-operatively. For the remaining ﬁve patients, three
resolved spontaneously at the 1 month CTA, and no further
adverse events were reported through 24 months. One
patient was treated successfully with a proximal extension
after 5 days and died after 1.5 years because of lung cancer.
The last patient died 5 days after the procedure because ofTable 1. Baseline characteristics.
Variable N ¼ 1263
N (%)
Age 80 290 (23.0)
Female gender 133 (10.5)
ASA III/IV 658 (52.1)a
Proximal graft diameter 32 or 36 398 (31.5)
Neck length <10 mm 27 (2.2)a
Neck thrombus/calciﬁcation (>50%) 74 (6.0)b
Neck taper 15% 218 (17.5)b
Maximum AAA diameter 65 317 (25.4)b
Suprarenal angle >60 44 (3.6)b
Infrarenal angle >75 62 (5.1)b
a Missing values 1%.
b Missing values >1% and 3%.bowel ischemia and myocardial infarction. None of the
intra-operative conversions were caused by type Ia endo-
leaks. Of the ﬁve renal coverage cases, one was subjected to
hepato-renal bypass and died after 22 days because of
multiorgan failure, one was successfully converted to open
repair, one was treated with renal artery stenting, and the
remaining two were treated conservatively without signiﬁ-
cant worsening of renal function. Only one of the delivery/
retrieval complications was possibly caused by complex
proximal anatomy. In this case, inability to withdraw the
delivery system was reported and the patient underwent
successful open conversion. The contribution of individual
adverse events to the composite endpoint is described in
Table 2.
Only neck length <10 mm (OR 4.9, 95% CI 1.1e22.6) and
presence of neck thrombus/calciﬁcation (OR 4.8, 95% CI
1.7e3.5) were independent risk factors for intra-operative
neck related adverse events (Table 3).
Intra-operative neck related adverse events occurred in
two (7.4%) patients with neck length <10 mm, and in ﬁve
(6.8%) patients with neck thrombus or calciﬁcation in >50%
of the neck circumference.
Post-operative neck related adverse events
After the index operation, 18 patients suffered neck related
adverse events. Of these, one was also included in the intra-
operative adverse events and the remaining 17 were
additional events. There were no endograft migrations, andevents.
Characteristic Event
(n ¼ 23)
Univariate
p value
Multivariate OR
(95% CI)
Age 80 7 (2.4%) 0.39 e
Female gender 4 (3.0%) 0.29 e
ASA III/IV 14 (2.1%) 0.40 e
Proximal graft diameter
32 or 36
8 (2.0%) 0.73 e
Neck length <10 mm 2 (7.4%) 0.047 4.9 (1.1e22.6)
Neck thrombus/
calciﬁcation (>50%)
5 (6.8%) 0.003 4.8 (1.7e13.5)
Neck taper 15% 2 (0.9%) 0.28 e
Maximum AAA
diameter 65
9 (2.8%) 0.13 e
Suprarenal angle >60 2 (4.5%) 0.18 e
Infrarenal angle >75 2 (3.2%) 0.39 e
Table 4. Post-operative neck related adverse events.
Post-operative neck related adverse events N ¼ 1263
N (%)
Endoleak type 1a 18 (1.4)
Corrected by remodeling the stent graft 2/18 (11)
Corrected with extension cuffs (prox or dist) 6/18 (33)
Corrected (others) 4/18 (22)
Proximal device migration (>10 mm) 0 (0)
Total (patients) 18 (1.4)
Figure 1. Receiver operating characteristic curve for the post-
operative risk model.
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endoleaks were imaging ﬁndings resulting from post-
operative surveillance, with no associated symptoms
(Table 4). Treatment was not offered to six patients for the
following reasons: metastatic cancer with very short life
expectancy (N ¼ 2), decision for surveillance with sponta-
neous resolution without intervention (N ¼ 2), one because
of decision of the patient, and another because of a deci-
sion of the physician (unﬁt for open conversion and no
endovascular solution available).
Female gender (HR 5.6, 95% CI 2.0e15.3), neck length
<10 mm (HR 8.9, 2.5e31.2), and AAA maximum diameter
65 mm (HR 6.4, 95% CI 2.3e17.7) were identiﬁed as in-
dependent risk factors for post-operative neck related
adverse events (Table 5). For patients with <10 mm prox-
imal neck, the crude complication rate was 11.1% (3/27
patients). For patients with large AAAs it was 3.5% (11/317),
and for female patients it was 4.5% (6/133).
A risk model was created, based on the proportional HR
obtained from the multivariate analysis. This model was
highly predictive of post-operative neck related adverse
events, with an AUC of 0.80 (Fig. 1), and a cutoff point of 6
was obtained. Based on this, patients were categorized into
high or low risk groups for post-operative adverse neck
events. This resulted in 335 patients, having a neck length
<10 mm or AAA maximum diameter >65 mm. NineTable 5. Risk factors for post-operative neck related adverse
events.
Characteristic Event
total ¼ 18
N (%)
Univariate
p value
Multivariate
HR (95% CI)
Age 80 6/290 (2.1) 0.26 e
Female gender 6/133 (4.5) 0.003 5.6 (2.0e15.3)
ASA III/IV 12/658 (1.8) 0.20 e
Proximal graft
diameter 32 or 36
4/398 (1.0) 0.40 e
Neck length
<10 mm
3/27 (11.1) 0.040 8.9 (2.5e31.2)
Neck thrombus/
calciﬁcation >50%
0/74 (0) e
Neck Taper 15% 4/218 (1.8) 0.99 e
Maximum AAA
diameter 65
11/317 (3.5) 0.61 6.4 (2.3e17.7)
Suprarenal angle
>60
3/44 (6.8) 0.003 e
Infrarenal angle
>75
3/62 (4.8) 0.010 epatients (2.7%) had both AAA diameter >65 mm and neck
length <10 mm. At 2 years, the event free survival expec-
tancy was 99% for low risk patients and 96% for high risk
patients (p < .001, Fig. 2).DISCUSSION
The proximal attachment site is a major contributor for
adverse outcome after EVAR, and is generally considered
the primary reason for EVAR turndown.8 The main ﬁnding
of this study is that risk factors for intra- and post-operative
neck related complications differ in type and relative
importance. Neck length was the most relevant predictor,
increasing the risk of intra-operative complications ﬁvefold
and the risk of mid-term complications ninefold, and
angulation, neck taper or diameter and presence of signif-
icant thrombus/calciﬁcation had no important contribution
for neck related adverse events at mid-term. Additionally,
this study suggests that the overall risk of neck related
complications is reduced compared with historical series,
implying an improvement in safety and efﬁcacy for EVAR.
The association between anatomical characteristics and
increase in risk has been well characterized in several
retrospective studies and registries and recently compiled
into two systematic reviews.9,10 In the meta-analysis by
Antoniou et al.,9 patients treated outside neck IFU were
compared with those treated according to different manu-
facturer’s recommendations. These authors found that
hostile neck patients had a threefold increase in the need
for intra-operative adjuncts to achieve proximal seal and a
fourfold increase in the risk of developing type 1 endoleaks
within the ﬁrst year. Stather et al.10 used different classiﬁ-
cation criteria, deﬁning hostile neck anatomy as any of the
following: neck length <15 mm, neck diameter >28 mm,
and angulation >60. They found a near twofold increase in
Figure 2. Estimated event free survival for patients at low and high
risk for post-operative neck related complications.
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endoleaks over time. Although these studies did not
attempt to evaluate the independent contribution of each
adverse neck characteristic, the proportional risk increase
for patients with adverse necks was comparable with this
study.
The determinant difference is, however, in the total
number of complications. Although both meta-analyses
identiﬁed the need for intra-operative adjunctive neck pro-
cedures in 3% to 5%, only 1.8% of 1263 patients included on
an intention to treat basis in this registry suffered intra-
operative neck related complications, and of these only 12
(0.9%) were type Ia endoleaks. More importantly, only 1.5%
of patients suffered from subsequent neck related compli-
cations, whereas meta-data revealed a much higherproportion, ranging from 5% to 11%, in an equivalent time
interval. In Engage patients, freedom from neck related
adverse events at 2 years was 96% for patients at high risk
for complications, and 99% for patients at low risk. Because
of the prospective and multicenter nature of this registry,
the chance of publication bias is smaller than in single center
observational studies, suggesting the reduction in incidence
may be even greater. The results of this study corroborate
that speciﬁc characteristics of this device make it a good
choice for treatment of less favorable neck anatomy. It also
conﬁrms the results of smaller, single center retrospective
studies that could be the reﬂection of bias and/or irrepro-
ducible experience of centers of excellence.11e15
The independent contribution of each patient charac-
teristic for neck related complications is a relevant ﬁnding.
Although the ENGAGE protocol recommended against in-
clusion of patients treated outside IFU, these were allowed
in the logic of consecutive enrollment. A total of 226 pa-
tients (18%) included were outside IFU, of which 112 (9%)
were caused by adverse proximal neck anatomy. These in-
clusions made it possible to test the inﬂuence of each in-
dividual neck related risk factor in a multivariate model,
allowing grading of individual risk with a high degree of
certainty, as reﬂected by the AUC of 0.8.
For intra-operative neck related adverse events, only
neck thrombus/calciﬁcation >50% and neck length
<10 mm were independent risk factors. These both
increased risk approximately ﬁvefold. The present ﬁndings
are compatible with previous literature on risk factors for
intra-operative complications, although thrombus could not
be differentiated from calciﬁcation. Interestingly, angulation
outside the IFU (supra-renal >60 and/or infra-renal >75)
was not a risk factor for intra-operative complications,
which conﬁrms a previous observation on the early results
of this endograft in patients with extreme angulation of the
proximal neck.16
At mid-term, the most important predictor for adverse
outcome was neck length, with <10 mm necks having a
ninefold risk increase. It is important to note that 3/27
patients (11.1%) of patients with neck length <10 mm were
identiﬁed as having a type Ia endoleak during follow up. As
no migrations were observed, it can be concluded that neck
length does not increase mid-term risk of migration with
this device, but does increase the risk of developing type 1a
endoleaks. This was expected, and parallels previous large
studies on the adverse inﬂuence of neck length.9 Given the
cost and treatment delay involved, fenestrated or branched
alternatives for patients with neck length <10 mm should
outweigh the risk involved in treatment of these adverse
neck patients with standard off the shelf infrarenal de-
vices.17e19 Also, fenestrated and branched technology
cannot be universally applied, because of anatomical con-
straints. The chimney techniques for endovascular repair of
short necks should be reserved, in the authors’ view, for
urgent or bailout cases, as the results are largely unknown.
It is not the intention of this study to defend standard EVAR
for patients with short proximal neck, but to present data
on the expected outcome if this solution is considered the
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repair may still be the preferred strategy for low risk pa-
tients with adverse proximal anatomy.
Aside from neck length, also female gender and
maximum AAA diameter were found to be risk factors at
mid-term, increasing risk 5.6 and 6.4-fold, respectively.
These differences cannot be explained by difﬁculties during
implantation, as these risk factors are not predictors of
technical failure. Aneurysm diameter is a well characterized
risk factor,20,21 probably because of the risk of graft
displacement in the aneurysm sac over time. Information of
the luminal volume (rather than diameter) or on endograft
displacement over time in patients at risk could help clarify
this issue. The gender effect is enigmatic, but may reﬂect a
higher anatomical complexity, not identiﬁed by the vari-
ables used for this study. This is a topic requiring further
clariﬁcation.
As a prospective registry, ENGAGE is limited by the
voluntary nature of inclusion. Also, it is a single graft study
and the results may not be applicable to other late genera-
tion devices. Despite these limitations, the ENGAGE registry
provides multicenter, worldwide data on a large sample of
patients reducing greatly the risk of selection bias and type II
statistical errors. Another relevant shortcoming is the rela-
tively low number of patients with neck length <10 mm,
which restricts the analysis for this most interesting sub-
group. Although this risk factor emerged in multivariate
models as highly predictive for both intra- and post-operative
complications, the conclusions must be interpreted with care
because of the overall low number of events. Another
important limitation is that the cutoff for migration in the
Registry was 10 mm as recommended in the Reporting
Standards,7 which may be excessive especially when
considering patients with complex anatomy. For illustration
purposes, patients were artiﬁcially divided into low and high
risk for post-operative adverse events using a cutoff. How-
ever, it is not suggested that this classiﬁcation should be used
in clinical practice, instead the hazard ratio for each predictor
is recommended as a more reliable method of estimating
risk. Finally, it is acknowledged that individual features may
have speciﬁc interactions that increase risk exponentially
(such as shortþ angulated proximal anatomy), and this is not
fully expressed in this or other publications regarding adverse
proximal anatomy. Expert opinion for case selection is still a
valuable asset for risk estimation in cases where multiple
adverse features co-exist.
In conclusion, the results of this study support the ade-
quacy of this device in the face of adverse neck anatomy,
and conﬁrm neck length as the most relevant anatomical
limitation for EVAR. Additionally, it conﬁrms the decline in
early to mid-term intervention rates with a newer genera-
tion device in a large patient sample. Lastly, it suggests that
neck related risk factors affect outcome and impact on
prognosis with varying degrees.FUNDING
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